Illustris Pharmaceuticals
Palo Alto, US · Founded 2016 · Delaware corporation
Founders & leadership
JL
Jaehoon LeeExecutive
MP
Mark PrygockiExecutive
GV
Gloria VasquezExecutive
JM
Jacob M. WaughNamed on SEC filing
Board
SK
Siak Khim TanBoard director
AH
Andrew HirschbergBoard director
JS
Jonah ShacknaiBoard director
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2016
▶$5MraisedMar 2017 · 14 investors · BiotechnologyRule 506(b)
▶$5MraisedMar 2017 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew HirschbergDirector
- Jonah ShacknaiDirector
- Jaehoon LeeExecutive Officer
- Mark PrygockiDirector, Executive Officer
- Jacob M. WaughExecutive Officer, Director
- Siak Khim TanDirector
- Gloria VasquezExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Illustris Pharmaceuticals raised?
- Illustris Pharmaceuticals has disclosed $5M raised across 1 round.
- Where is Illustris Pharmaceuticals headquartered?
- Illustris Pharmaceuticals is headquartered in Palo Alto, US.